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Abstract
Major biological effects of UVB are attributed to cyclobutane pyrimidine dimers (CPDs), the
most common photolesions formed on DNA. To investigate the contribution of CPDs to
UVB-induced changes of gene expression, a model system was established by transfecting
keratinocytes with pseudouridine-modified mRNA (Ψ-mRNA) encoding CPD-photolyase.
Microarray analyses of this model system demonstrated that more than 50% of the gene
expression altered by UVB was mediated by CPD photolesions. Functional classification
of the gene targets revealed strong effects of CPDs on the regulation of the cell cycle and
transcriptional machineries. To confirm the microarray data, cell cycle-regulatory genes,
CCNE1 and CDKN2B that were induced exclusively by CPDs were selected for further
investigation. Following UVB irradiation, expression of these genes increased significantly
at both mRNA and protein levels, but not in cells transfected with CPD-photolyaseΨ-mRNA
and exposed to photoreactivating light. Treatment of cells with inhibitors of c-Jun N-terminal
kinase (JNK) blocked the UVB-dependent upregulation of both genes suggesting a role for
JNK in relaying the signal of UVB-induced CPDs into transcriptional responses. Thus,
photolyase mRNA-based experimental platform demonstrates CPD-dependent and -inde-
pendent events of UVB-induced cellular responses, and, as such, has the potential to iden-
tify novel molecular targets for treatment of UVB-mediated skin diseases.
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Introduction
The incidence of keratinocyte-derived skin cancer, which is the most common human malig-
nancy, continues to increase worldwide, thus presenting a serious challenge to healthcare sys-
tems [1]. Ultraviolet B (UVB) (290–320 nm) radiation is the main environmental risk factor
for sunburn, skin carcinogenesis and premature skin ageing [2,3]. Cyclobutane pyrimidine
dimers (CPDs) are the predominant photolesions caused by UVB radiation, and primarily they
are responsible for these adverse effects [4]. CPDs are the most deleterious and premutagenic
photolesions, due to their ability to distort the structure of the DNA, leading to disturbance of
DNA replication and transcription [5,6]. The pathogenetic role of CPDs is further substanti-
ated by presence of CPD-related signature mutations in genes involved in the formation of
skin cancers [7], as well as, by the correlation between the action spectrum value for the induc-
tion of CPD photolesions and development of UV-induced skin cancer in animal models [8,9].
In addition, CPDs have been shown to mediate UVB-induced erythema [10] and immunosup-
pression [11,12]. Naturally, DNA lesions, including CPDs are excised by the nucleotide exci-
sion repair (NER) system of human keratinocytes [13]. However, the rate and accuracy of
DNA repair by NER are suboptimal [14].
CPD-photolyase is a structure-specific DNA repair enzyme that specifically binds and
cleaves CPDs using the energy of visible light (“photoreactivation”), thereby simply and rapidly
restoring DNA integrity [15]. This enzyme functions in diverse organisms from bacteria to ver-
tebrates but is absent in placental mammals, including humans, that must rely solely on the
less potent NER to repair UV-induced DNA lesions [16]. Sunscreen lotions containing lipo-
somal-encapsulated bacterial photolyase or CPD-specific endonuclease have been marketed
for preventing UV-induced skin damages [17], especially in patients with NER-deficiency [18].
In a previous study, we applied a novel mRNA-based gene delivery method, and demon-
strated that transfection of pseudouridine-modified mRNA (C-mRNA) encoding Potorous tri-
dactylus CPD-photolyase (CPD-PL) into human keratinocytes leads to rapid repair of DNA-
damage [19]. Pseudouridine modifications increase mRNA stability [20], make it highly trans-
latable [21,22] and abolish immunogenicity of the RNA [23]. It is well documented that CPD
lesions are considered to be the principal mediator of UV-induced mutagenesis and DNA dou-
ble-strand break (DSB) signalling [7,9]. However, so far, it has been unclear how CPDs change
gene expression and cell activities. To gain insight, we performed a global analysis (microarray)
of molecular networks. Most dermatological studies, in which microarray technology was used,
analysed differential expression of genes comparing normal and pathologic skin samples in
order to identify genes associated with a specific skin condition or with tumor progression
[24–28]. Microarray platforms were also used to identify UV-regulated genes and have uncov-
ered that significant change in the expression profiles of hundreds of genes are induced by UV.
Altered expression of genes in response to UV irradiation have been determined in epidermal
keratinocytes [29], fibroblasts [30] and melanocytes [31]. Microarray experiments have dem-
onstrated that UVB exposure affects several biological processes indicating the complexity of
UV-induced cellular activities. Studies performed on human keratinocytes identified UVB-
induced genes that were involved in proteasome-mediated pathways, cytoskeleton organiza-
tion, cell cycle and apoptosis networks, and control of basal transcription and translation lead-
ing to inhibition of cell growth [29,32–34]. Furthermore, it has been shown that the repair rate
of DNA lesions alters the UV-induced transcription profile, thus suggesting that adequate
removal of the photoproducts could avoid UV-related cutaneous pathologies [35]. However,
until now, there was no suitable experimental platform to identify directly CPD-responsive
genes in human cells, thus distinguish CPD-regulated cellular mechanisms from those
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mediated by other UVB-induced derivatives, including diverse photoproducts, reactive oxygen
species, cross-linked protein-DNA and other damaged macromolecules.
Here, we present data obtained by using human keratinocytes transfected with in vitro-syn-
thesized nucleoside-modified mRNA encoding a marsupial-specific CPD-photolyase. This
model system enabled us to distinguish between CPD-dependent and-independent cellular
processes. We determined the UVB-induced transcriptional responses in human keratinocytes
using the combination of a CPD-specific photolyaseC-mRNA delivery with a genomics
approach. Pathway analysis revealed a strong effect of CPDs on the expression levels of genes
involved in the control of the cell cycle and transcriptional machineries. Our findings demon-
strate that the c-Jun N-terminal kinase (JNK) signalling pathway plays a role in conversion of
the cues generated by UVB-induced CPDs into a transcriptional response.
Materials and Methods
RNA synthesis
Messenger RNAs were generated as previously described [19], using linearized plasmids
(pTEV-CPD-PL-A101 and pTEVeGFP-A101) encoding codon-optimized Potorous CPD-
photolyase (CPD-PLC-mRNA) and enhanced green fluorescent protein (eGFPC-mRNA).
The CPD-photolyase gene from Potorous tridactylus (rat kangaroo) was synthesized by Entele-
chon (Bad Abbach, Germany). The Megascript T7 RNA polymerase kit (Ambion, Austin, TX)
was used for transcription, and UTP was replaced with pseudouridine triphosphate (TriLink,
San Diego, CA) [21]. To remove the template DNA Turbo DNase (Ambion) was added to the
reaction mix. Pseudouridine-modified mRNAs were HPLC-purified as described [36] and pro-
vided with cap1 generated by using the m7G capping enzyme and 20-O-methyltransferase
according to the manufacturer (CellScript, Madison, WI). The mRNAs were transcribed to
contain 101 nt-long 3’ poly(A) tail. Small aliquots of RNA samples were stored in siliconized
tubes at -20°C.
Keratinocyte cell line
An established HaCaT cell line [37] was maintained in high glucose DMEM (Lonza, Verviers,
Belgium) supplemented with 2 mM L-glutamine (Lonza), 10% fetal bovine serum (Lonza) and
0.5% antibiotic/antimycotic solution (Sigma-Aldrich, St. Louis, MO, USA) at 37°C with 5%
CO2.
Transient transfection and treatments
Transient transfection ofC-mRNA into HaCaT cells, UVB exposure and photoreactivation
experiments were carried out, as previously described [19], except that a ratio of mRNA
(0.25 μg) and Lipofectamine LTX-PLUS (Life Technologies) reagent (1.0 μl) in a final volume
of 100 μl EpiLife keratinocyte growth medium (Life Technologies, Carlsbad, CA, USA) was
used. Following a two-hour transfection, the lipofectamine-RNA complex was replaced with
100 μl fresh culture medium. At 12 h post transfection, the cell monolayer in a well of a 96-well
plate, was covered with 50 μl Dulbecco’s phosphate buffer saline (Life Technologies) and sub-
jected to 20 mJ/cm2 UVB using two TL-20W/12 tubes (Philips). Proper dosage of UVB was
determined by a UVX Digital Radiometer (UVP Inc., San Gabriel, CA, USA). Immediately
after UVB treatment, cells were exposed to visible light (“photoreactivation”) using F18W Day-
light fluorescent tubes (Sylvania) or kept in the dark for one hour. At 5 and 23 h following
photoreactivation, total RNA and genomic DNA were isolated from the cells.
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Enzyme-linked immunosorbent assay (ELISA)
Genomic DNA was extracted from HaCaT cell line using the Qiagen Blood and Cell Culture
kit (Qiagen, Hilden, Germany), according to the manufacturer. A direct ELISA was applied for
detection of CPD, as previously described [19]. Anti-CPD monoclonal antibody (TDM-2,
Cosmo Bio, Tokyo, Japan) diluted in PBS (1:1000) was used as primary antibody.
Microarray analysis
Total RNA was isolated from HaCaT cells using Trizol reagent (MRC, Cincinnati, OH, USA),
according to the manufacturer’s instructions. RNA samples were treated by DNase I (Fermen-
tas, St. Leon-Rot, Germany) and their quality were analyzed using an Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA). Gene expression profiling of HaCaT cells trans-
fected with CPD-photolyase mRNA was performed using a service provider (ChromoScience,
Budapest, Hungary, http://www.chromoscience.hu). Briefly, cyanine 3-labeled cRNA was syn-
thesized from 200 ng total RNA by the QuickAmp Labeling Kit (Agilent Technologies),
according to the manufacturer. For each sample, 1650 ng of one-color labeled cRNA was
hybridized to an Agilent 4x44 KWhole Human Genome Oligo (Agilent Technologies) micro-
array platform at 65°C for 17 h. All further steps were carried out according to the manufac-
turer (Agilent Technologies). The slides were scanned with the Agilent Microarray Scanner.
Data were then normalized by the Feature Extraction software version 9.5 (Agilent Technolo-
gies) with default settings for one-color oligonucleotide microarrays and then transferred to
GeneSpringGX program (Agilent Technologies) for further statistical evaluation. In Gene-
Spring, the normalization and data transformation steps recommended by Agilent Technolo-
gies for one-color data were applied at each time point. Microarray data have been submitted
to Gene Expression Omnibus (GEO) [38] database and can be retrieved at http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE65034 (GEO Series accession number: GSE65034).
Three replicates of the following 3 types of CPD-PLC-mRNA transfected samples were stud-
ied by the microarray: non-irradiated, UVB-irradiated without photoreactivating light (inac-
tive CPD-photolyase), UVB-irradiated plus photoreactivated (active CPD-photolyase). Genes
showing statistically significant 2-fold change were selected for further study by Ingenuity
Pathway Analysis (IPA, Qiagen; http://www.ingenuity.com/products/ipa) and Database for
Annotation, Visualization and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov)
gene functional classification tool.
Real-time quantitative RT-PCR analysis
To validate the microarray data, real-time quantitative reverse transcription (RT)-PCR was
used. RT was performed using the High-Capacity cDNA Reverse Transcription Kit (Life Tech-
nologies), according to the manufacturer. RT reactions contained 500–500 ng of RNA. To
quantitate the expression of candidate genes, the following TaqMan Gene Expression assays
(Life Technologies) were used: ATF3 (Hs00231069_m1), CCNE1 (Hs01026536_m1), CDKN2B
(p15INK4b) (Hs00793225_m1), EGR1 (Hs00152928_m1), ID2 (Hs04187239_m1), PTGS2
(COX-2) (Hs00153133_m1), RUNX1 (Hs00231079_m1), SNAI2 (Hs00950344_m1), the
sequences are proprietary and not released by the company. To determine mRNA expression
of SNAI1 the following custom-designed primers and probe set were used: Forward primer: 5’-
ACT ATG CCG CGC TCT TTC-3’; Reverse primer: 5’-GCT GGA AGG TAA ACT CTG
GAT-3’; and the probe sequence is: 5’-[6-carboxyfluorescein (FAM)] AAT CGG AAG CCT
AAC TAC AGC GAG C [tetramethylrhodamine (TAMRA)]-3’. The composition of RT mixes,
the PCR reactions and the RT-PCR protocols were carried out as previously described [19]
using the ABI 7900 HT Sequence Detection System (Life Technologies). Relative RNA
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expression values were calculated using the 2-ΔΔCt method [39] in which expression levels in
samples containing active CPD-photolyase were compared to those containing inactive one.
SDHA ((Hs00188166_m1) and PGK1 (Hs00943178_g1) mRNA levels that showed the smallest
variation upon UVB exposure in keratinocytes [40] were used for normalization.
Western blot analysis
For Western blot analyses, whole cell extracts were prepared, as previously described [19]. Pro-
teins (10 μg) were separated on 12% polyacrylamide gels and transferred to nitrocellulose
membranes (BioRad, Berkeley, CA, USA). After blocking the membranes in 5% non-fat dry
milk, the membranes were incubated with primary antibodies diluted (1:750) in 5% skimmed
milk at 4°C overnight, then with the appropriate secondary antibodies (1:3000) at room tem-
perature for 1 hour. The following primary antibodies were used: anti-CCNE1 (4129), anti-ß-
actin (3700) (Cell Signaling Technology, Danvers, MA, USA) and anti-CDKN2B (p15INK4b)
(MA1-12294, Thermo Fisher Scientific, Rockford, IL, USA). Goat anti-mouse or anti-rabbit
IgG conjugated with horseradish peroxidase (HRP) was used as a secondary antibody
(BioRad). The visualization of proteins was achieved with ECL Prime Western blotting detec-
tion system (GE Healthcare, Little Chalfont, UK) and densitometry was performed using Ima-
geJ public software (NIH, Bethesda, MD, USA).
Inhibitor treatment
Keratinocytes at 85% confluency were transfected with lipofectamine-complexed CPD-PLC-
mRNA. Twelve hours later, cells were pretreated with specific inhibitors of JNK (SP600125),
p38 MAPK (SB203580) or AKT (MK-2206) at a final concentration of 40 μM, 10 μM and
10 μM, respectively for 1 hour before treatment with UVB and subsequent photoreactivation.
All chemical agents were purchased from SelleckChem (Selleck Chemicals, Houston, TX, USA)
and were dissolved in dimethyl sulfoxide (DMSO) (Sigma-Aldrich). Stock solutions were pre-
pared according to the manufacturer and stored at -20°C.
Statistical evaluation
Identification of genes differentially expressed in microarray experiments was carried out by
the unpaired, Student’s t-test followed by Benjamini-Hochberg correction. Statistical analysis
of qRT-PCR data was performed using GraphPad Prism 5 software (GraphPad Software Inc.,
San Diego, CA, USA). The significance of differences in terms of mRNA expression comparing
UVB-irradiated samples to non-irradiated ones, or UVB-irradiated plus photoreactivated
(active CPD-photolyase) samples to non-photoreactivated (inactive CPD-photolyase) samples,
respectively, was determined by the two-tailed, unpaired t-test. A p value of equal to or less
than 0.05 was considered statistically significant.
Results
Accelerated removal of CPD lesions in keratinocytes transfected with
CPD-photolyase mRNA
To test the enzymatic activity of CPD-photolyase translated in HaCaT cells from the transfected
mRNA (CPD-PLC-mRNA), cells were subjected to a physiological dose of UVB (20 mJ/cm2)
12 h after transfection of lipofectamine-complexed CPD-PLC-mRNA. Immediately thereafter,
cells were either exposed to photoreactivating light, or left in the dark for 1 hour. Cells were har-
vested 5 and 23 hours later, and CPD-specific ELISA was performed to measure the amount of
CPDs formed in genomic DNA. The amount of CPDs in CPD-PLC-mRNA transfected cells
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was reduced by 90% in those receiving photoreactivating light (photoreactivated), as compared
to cells kept in the dark (non-photoreactivated) (Fig 1). Cells transfected with control eGFPC-
mRNA contained the highest amount of CPD lesions at both 6 and 24 h after UVB irradiation
(Fig 1). A reduced amount of CPD lesions were measured in all irradiated samples at 24 h vs. at
6 h due to slower endogenous NER-mediated DNA repair.
CPD-dependent changes were distinguished within the UVB-induced
alterations of gene expression in human keratinocytes
To determine the CPD-dependent gene expression profile of human keratinocytes exposed to
UVB irradiation, an oligonucleotide-based DNA microarray analysis was performed in which
HaCaT cells transfected with CPD-PLC-mRNA were used. Total RNA was isolated at 6 and
Fig 1. Accelerated photorepair of CPDs in HaCaT cells transfected with CPD-PLΨ-mRNA.HaCaT cells
were transfected with lipofectamine-complexedΨ-mRNA encoding CPD-photolyase. Twelve hours later, cells
were subjected to 20mJ/cm2 UVB and immediately exposed to photoreactivating light (photoreactivated) or left
in the dark (non-photoreactivated) for 1 h and thenmaintained at 37°C for 5 and 23 hs. After incubation at 5 and
23 h, genomic DNA was isolated at the indicated times after UVB irradiation and the amount of CPDs was
measured by ELISA. The values were calculated relative to those obtained with cells that were not UVB-
irradiated. Significance was assessed by unpaired, two-sample t-test, p<0.05. Error bars represent the
standard error of the mean from three experiments performed independently.
doi:10.1371/journal.pone.0131141.g001
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24 h after UVB exposure and subsequent photoreactivation (or not). Gene expression values of
UVB-irradiated plus photoreactivated samples (active CPD-photolyase) were compared to
non-irradiated samples and to those that were UVB irradiated, but left without photoreactiva-
tion (inactive CPD-photolyase). UVB irradiated, but non-photoreactivated samples were also
compared to non-irradiated samples. Cut-off values for changes in gene expression were set
at ± 2-fold, and according to this criterion, expression levels of 2,370 out of 41,000 genes
were changed at 6 or 24 h after UVB exposure. Altered expression of 1,334 (56%) of UVB-regu-
lated genes was restored in cells that contained active CPD-photolyase indicating that the
changes in the expression of these genes were CPD-dependent (S1 Fig). Importantly, more
CPD-dependent gene expression changes (1,008 out of 1,334 genes) were observed at 6 h vs.
24 h, potentially due to the higher difference in CPD levels at 6 h comparing cells with active
CPD-photolyase to those with inactive one (S1 Fig, S1 and S2 Tables). There are other reasons,
such as transient expression of induced genes. On the other hand, CPD-dependent genes repre-
sented more than half of the UVB-regulated genes (1008 out of 1743 genes and 326 out of 627
genes at 6 and 24 h after UVB irradiation, respectively) at both time points after the exposure
(S1 Fig, S1 and S2 Tables). These data suggest that UVB-induced CPDs mediate a significant
portion of the transcriptional alterations after 6 and 24 hours in response to UVB irradiation of
human keratinocytes.
UVB-induced, CPD-dependent genes are associated with cellular stress
responses
To determine possible network interactions and associated biological functions of CPD-regu-
lated genes, datasets representing all the differentially expressed genes derived from microarray
analyses were imported into IPA and DAVID software. Using these applications, we deter-
mined that a majority of CPD-dependent genes at 6 h after UVB exposure belong to the regula-
tory network of Cell Cycle and Gene Expression, while those at the 24 h belong to the network
of Cellular Development, Growth and Proliferation (S2A Fig, S3A–S3G Fig). The top-rated net-
work of CPD-regulated genes at 6 h after UVB irradiation was centered around a proto-onco-
gene (c-Jun); the prostaglandin-endoperoxide synthase 2 (PTGS2), which is a major mediator
of inflammation, and the glucocorticoid receptor (NR3C1), which mainly functions as a tran-
scription factor (S2B Fig). In addition, c-Jun and interleukin 6 (IL6), the transcriptional regula-
tor nuclear factor kappa B (NF-κB), p38 and the protein kinase ERK were central nodes in the
top network of CPD-dependent genes at 24 h after UVB exposure (S2C Fig). 122 out of the
1008 CPD-regulated genes belonged to the best-scored IPA network at 6 h after UVB and
60 out of the 326 CPD-regulated genes at 24 h after the exposure (S2A Fig). Functional classifi-
cation of CPD-regulated genes within networks (S2B and S2C Fig) suggested that a wide range
of cell cycle-regulatory genes, positive or negative regulators of the transcriptional and cell
recovery machineries, proto-oncogenes, apoptosis and protein kinase related genes were
uniquely induced or repressed by CPD photolesions (S3A–S3G Fig). Nine genes regulated by
CPDs were selected for further investigation based on the microarray data and their involve-
ment in cell cycle regulation (CCNE1, CDKN2B), transcriptional regulation (ATF3, EGR1, ID2,
RUNX1), epithelial to mesenchymal transition (SNAI1, SNAI2) and inflammation (PTGS2)
(Table 1).
CPD-dependency of transcriptional changes of 9 genes selected on the
basis of microarray data were confirmed by RT-qPCR
To validate the microarray data, we employed real time quantitative RT-PCR analyses.
Regarding ATF3[41], EGR1[41], ID2[42], SNAI1[43], SNAI2[43], PTGS2[44] and CCNE1[45]
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UV-induced upregulation of these genes has been previously described [41–45], and our results
were in agreement with the literature. We found significant upregulation of the expression of
CDKN2B (p15INK4b), and downregulation of the expression of RUNX1 in response to UVB
(Fig 2). Furthermore, presence of active CPD-photolyase significantly prevented the changes in
the expression of all tested genes (Fig 2), thereby confirming the results of the microarray
analysis.
Table 1. Summarized fold change values by microarray results of the selected 9 CPD-dependent genes.
6 h after UVB irradiation 24 h after UVB irradiation








NM_001040619 ATF3 activating transcription factor 3 5.65 -3.30 1.85 -1.90
NM_001238 CCNE1 cyclin E1 2.87 -2.14 1.17 1.13
NM_004936 CDKN2B cyclin-dependent kinase inhibitor
2B
7.76 -3.36 2.05 -2.06
NM_001964 EGR1 early growth response 1 2.51 -3.95 3.38 -2.39
NM_002166 ID2 inhibitor of DNA binding 2 4.35 -3.89 -2.09 1.45
NM_000963 PTGS2 prostaglandin-endoperoxide
synthase 2
6.75 -3.72 4.66 -3.04
NM_001001890 RUNX1 runt-related transcription factor 1 -4.45 4.36 1.05 1.09
NM_005985 SNAI1 snail family zinc finger 1 6.44 -3.44 2.76 -2.59
NM_003068 SNAI2 snail family zinc finger 2 2.39 -2.15 1.59 -1.24
active PL: samples containing active CPD-photolyase, inactive PL: samples containing inactive CPD-photolyase.
doi:10.1371/journal.pone.0131141.t001
Fig 2. Experimental verification of microarray results for 9 selected genes.HaCaT cells were exposed to 20 mJ/cm2 UVB at 12 h after delivery of
CPD-PLΨ-mRNA. Immediately thereafter, cells were either subjected to photoreactivating light (active CPD-photolyase) or left in the dark (inactive CPD-
photolyase) for 1 h. Following incubation total RNA was extracted at 5 and 23 h, then real-time RT-qPCRwas performed to validate the CPD-dependent
expression of ATF3, CCNE1, CDKN2B, EGR1, ID2, PTGS2, RUNX1, SNAI1 and SNAI2. Values measured in UVB irradiated cells with or without
photoreactivation were related to those measured in non-UVB irradiated cells that were transfected controlΨ-mRNA, (pecked lines). Asterisks indicate
significant differences (two-tailed, unpaired t-test; p<0.05) between photoreactivated (active CPD-photolyase) and non-photoreactivated (inactive CPD-
photolyase) samples. The results of RT-qPCR are means ± SEM from three independent experiments in triplicate.
doi:10.1371/journal.pone.0131141.g002
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Overexpression of cyclin E1 (CCNE1) and p15INK4b (CDKN2B) proteins
in response to UVB is dependent on the generation of CPD and
activation of JNK pathway
For further investigation, we selected two cell cycle-regulatory genes that were less character-
ized, related to their involvement in UVB-induced stress response. We have found that the
expression of cyclin E1 and p15INK4b proteins were significantly increased at 24 h after
UVB irradiation, but this increase was prevented by active CPD-photolyase (Fig 3A and 3B).
UVB can activate various protein kinases to regulate cell proliferation and survival pathways
in human keratinocytes [46]. To investigate the signalling pathways involved in modulation
of cyclin E1 and p15INK4b expression upon UVB exposure, HaCaT cells transfected with
CPD-PLC-mRNA were first exposed to specific inhibitors of JNK (SP600125), p38 MAPK
(SB203580) or AKT (MK-2206) for 1 h, then immediately subjected to 20 mJ/cm2 of UVB and
subsequent photoreactivating light (active CPD-photolyase) or not (inactive CPD-photolyase).
After photoreactivation, cells were cultured in keratinocyte medium containing inhibitor until
harvested at 6 and 24 h. We determined the expression of cyclin E1 and p15INK4b proteins by
western blot analysis. While suppression of p38 MAPK or AKT had no effect on UVB-induced
increase in the levels of these proteins (data not shown), we found that the treatment of cells
with the JNK inhibitor SP600125 abolished the induction of cyclin E1 and p15INK4b protein
expression at 24 h after UVB (Fig 4). Taken together, these results indicate that activation of
JNK could be responsible for transducing the signal from CPD lesions towards the induction
of CCNE1 and CDKN2B gene expression in UVB-exposed human keratinocytes.
Discussion
The use of in vitro-transcribed messenger RNA for delivery of genetic material into mamma-
lian cells has grown into a novel and alternative tool to oust DNA-based gene transfer in the
last decade [47]. It is well documented that cells transfected with mRNA can synthesize the
encoded protein [47]. We have previously shown that human cultured keratinocytes expressing
CPD-photolyase from transfected in vitro-synthesized mRNA are suitable for investigating the
cellular and molecular effects of UVB-induced CPDs [19]. Optimization of the transfection
procedure resulted in 90% removal of CPDs within the first hour of photoreactivation, making
this platform highly suitable for identification of CPD-dependent gene expression changes
after UVB exposure. UV-induced mutagenesis is attributed to CPDs, which under normal con-
ditions are repaired by the slow NER system [14]. Mutations in NER genes result in a less effec-
tive and error-prone DNA repair, which increases the probability of developing cancer [48].
Identification of the genes regulated by CPD photolesions might have clinical relevance, as it
will facilitate defining novel targets for diagnosis or treatment of UVB-mediated skin diseases.
We identified 1334 CPD-responsive genes, which represent more than 50% of the genes regu-
lated by UVB at 6 and 24 h after the exposure, indicating that CPDs are major contributors to
altered gene expression induced by UVB irradiation, as well as, to the harmful effects of UVC
exposure [49]. These data also indicate that transcriptional change of a significant number of
genes remained the same at 6 or 24 h after UVB exposure and subsequent photoreactivation in
cells transfected withC-mRNA encoding CPD-specific photolyase. This confirms that other
UVB-related factors also play a role in gene regulation, but are independent from CPDs. Such
factors include 6–4 photoproduct (6-4PP), which is the second most abundant UV-induced
photolesion formed in DNA [50]. However, the removal of these photoproducts from the
mammalian genome is very fast [14], thus 6-4PPs could potentially contribute to the early
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wave of UV-induced transcriptional response [49]. In addition to 6-4PPs, other UVB-induced
products, including reactive oxygen species, oxidized nucleobases (e.g. 8-oxo-7,8-dihydroxy-
guanine), crosslinked protein-DNA are likely to be responsible for CPD-independent tran-
scriptional changes in human keratinocytes. A significant number of CPD-responsive genes
(738 and 250 genes at 6 h and 24 h after the exposure, respectively) were downregulated, most
likely due to the stalling of RNA polymerase II and inhibition of transcription elongation
Fig 3. Photorepair of CPDs prevents altered expression of cyclin E1 and p15INK4b protein in UVB irradiated HaCaT cells.Cells were transfected
with lipofectamine-complexed CPD-PLΨ-mRNA, 12 hs later irradiated with 20 mJ/cm2 UVB and immediately exposed to photoreactivating light (active CPD-
photolyase) or kept in the dark (inactive CPD-photolyase) for 1 h. Subsequently, cells were cultured at 37°C until harvested at the indicated time after UVB
irradiation. (A) The expression of cyclin E1 and p15INK4b were analyzed byWestern blot. (B) Quantitation of western blots displays relative changes in
protein expression normalized to β-actin. Pixel densities were calculated relative to those obtained with cells that were not UVB irradiated (pecked lines).
Significance was assessed by two-tailed, unpaired t-test (asterisk, p<0.05) showing differences between photoreactivated and non-photoreactivated
samples. Error bars represent the standard error of the mean. The results are means of three independent experiments.
doi:10.1371/journal.pone.0131141.g003
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caused by UVB-induced DNA damage [51]. Furthermore, we found a markedly higher number
of CPD-dependent genes to show altered expression levels at 6 h, as compared to 24 h.
Herein, we mainly focused on analysis of genes regulated by UVB-induced CPD lesions at
6 h after the exposure. Top functional categories were determined among these genes, and we
found that CPD-related gene expression changes were mainly associated with regulation of the
cell cycle and transcriptional machineries in response to UVB irradiation of human keratino-
cytes. Molecular studies have provided evidence that recognition of DNA damage, including
UVB-induced photolesions, can temporarily halt cell cycle progression, allowing time for
cells to repair damages prior to replication [52,53]. Unsuccessful repair of these photoproducts
initiates intracellular apoptotic signalling in order to prevent the multiplication of mutated
chromosomes, but may lead to a permanent cell cycle block, genomic instability or skin carci-
nogenesis [3,9,12,54]. The importance of cell cycle arrest is supported by studies in which the
function of genes encoding cell cycle inhibitors (INK4 and Cip/Kip family) and cell cycle
regulators (p53, Rb) were analysed [55–58]. A strong correlation has been demonstrated
between the occurrence of CPD-caused “UV fingerprint”mutations in p53 gene and the devel-
opment of skin cancer [59]. In addition, p53 was also shown to be regulated by UVB at a post-
translational rather than at the transcriptional level [60]. And that might be the reason, why
we did not detect a change in the expression of p53 in cells exposed to UVB (GEO database—
GSE65034), but observed CPD-dependent changes in mRNA levels of several p53 target genes,
includingMDM2, ATF3, CCNE1, SNAI1, CDK7,WWOX (Fig 2, S1 and S2 Tables). These data
demonstrated that germline mutations, chemical inactivation or alteration of cell cycle key reg-
ulators, including p53, result in perturbations of cell cycle checkpoint control leading to the
transformation of the cells. Therefore, adequate regulation of cell cycle arrest is critical to elimi-
nate mutated and potentially malignant cells. According to our microarray data, CPDs are the
primary cause of UVB-induced cell cycle arrest. This finding is further supported by data dem-
onstrating that photolyase-dependent removal of CPDs prevents UVB-induced upregulation
of negative regulators of cell cycle, including BTG2, CDKN2B (p15), CDKN1C (p57),
Fig 4. Induction of cyclin E1 and p15INK4b protein expression upon UVB exposure is regulated through the JNK signalling pathway in HaCaT
cells. Keratinocytes transfected with CPD-PLΨ-mRNA were incubated in serum-free medium supplemented with JNK inhibitor (SP600125) for 1 h.
Immediately thereafter, cells were irradiated with a physiological dose of UVB or left untreated followed by exposure to photoreactivating light (or not) for 1 h.
The cells were cultured further in serum-free medium supplemented with the inhibitor. Cells were harvested for western blot assay at the indicated time.
Protein levels of cyclin E1, p15INK4b, and β-actin are noted. The figure shows representative results from three independent experiments.
doi:10.1371/journal.pone.0131141.g004
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GADD45B, and RGS2 (S3A Fig). Our microarray experiment provides new data that CPDs are
the primary cause of UVB-induced cell cycle arrest [52].
Among the regulated cell cycle-related genes, CDKN2B, which is involved in G1/S check-
point control of cell cycle as well as gain and loss events for p15INK4b have been extensively
studied in recent years [61,62] with less established roles in UVB-mediated cellular damage in
keratinocyte biology. Results of our RT-qPCR and western blotting analyses showed that the
CPD-photolyase mediated repair of UVB-induced CPDs prevented increased expression of
CDKN2B (p15INK4b) mRNA and protein. Loss of p15INK4b function and CDKN2Bmuta-
tions has been described in several types of tumors [57,61–63] confirming that the inactivation
of p15INK4b significantly contributes to the transformation of normal cells into cancer cells.
Mutations and deletions in p15INK4b have been demonstrated in melanoma tumorigenesis
[64], and considered to be a heightened risk of melanoma according to several wide-range
examinations [65,66]. Altered expression of CDKN2B (p15INK4b) mRNA level and new muta-
tions have been detected in patients with actinic keratosis (AK) suggesting its possible role in
AK development [67]. Taken together, our data strongly suggest the high relevance of CPDs in
disruption of cell cycle progression.
In addition to cell cycle arrest, UVB exposure may affect the cell cycle machinery and cell
proliferation via regulation of target genes involved in apoptosis or inflammation. The most
studied gene associated with UVB-mediated cellular processes is cyclooxygenase 2 (COX-2 or
PTGS2). Its upregulation is described as a diagnostic marker and predictive factor in most
tumors and other diseases related to chronic inflammation [68,69]. The role of COX-2 inhibi-
tion is paramount important in prevention and treatment of different types of cancer [70]. In
vivo studies have demonstrated that the use of specific inhibitors of COX-2 leads to accumula-
tion of cells in G0/G1 phase of cell cycle and reduced proliferation of cancer cells [69]. Our
study confirmed upregulation of COX-2 in UVB-irradiated keratinocytes, and here we also
demonstrated that its increased expression was CPD-dependent (Fig 2, S3E Fig).
Furthermore, we have identified another gene, CCNE1, which similarly to COX-2 related to
enhanced cell proliferation and upregulated in a CPD-dependent manner. A study using a
mouse model has shown that the cell cycle disturbance in epidermal keratinocytes subjected to
an erythematogenic dose of UVB irradiation is at least in part caused by increased expression
of cyclins, including cyclin E1 [71]. Their data suggests that UVB-induced hyperplasia and
tumorigenesis is partly mediated by the upregulation of cyclin E1 [71], it however has not been
investigated in humans. Several studies suggested that CCNE1may represent a useful prognos-
tic marker and has the potential to be a target for therapy in breast and ovarian cancer [72,73].
This has not yet been investigated in skin cancer.
The second best scored gene network was related to transcriptional machinery. We vali-
dated the microarray results for six transcriptional regulators, ATF3[74], EGR1[75], ID2[76],
RUNX1[77], SNAI1[78] and SNAI2[78]. Mutations or altered expression of these genes has
been reported in various types of cancer, including skin cancer [74–78]. Upregulation of ATF3
[41], EGR1[41], ID2[42], SNAI1[43] and SNAI2[43] has also been implicated in UV-induced
cellular stress responses [41–43]. Here, we have demonstrated that expression of these tran-
scription regulators are CPD-dependent, which could serve as novel biomarkers for evaluation
of the involvement of UVB in various photosensitive skin disorders or skin cancers. Our find-
ings underscore that UVB-induced CPD photolesions play a critical role in tumor develop-
ment, including skin carcinogenesis and not only by induction of mutations but also by
changing the expression of physiologically important genes.
The question of how CPD photolesions activate intracellular signalling and how they modu-
late the expression of genes in cellular mechanisms (e.g. cell cycle arrest) in response to UVB
irradiation has not been answered. Using CPD-photolyase expressing transgenic mice, it has
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been shown previously that unrepaired CPD photolesions are the major mediator of UV-
induced transcriptional responses and induce S-phase cell cycle arrest [49]. UV radiation acti-
vates different signal transduction pathways in a wavelength and dose-dependent manner [79].
It is well established that these signal pathways are regulated by specific protein kinases includ-
ing p38 kinase, PKC, AKT and JNK, which play a crucial role in the response network to skin
damage caused by UV exposure [46]. We examined how specific inhibitors of protein kinases,
such as p38 kinase, AKT and JNK, affect gene expression changes initiated by CPD photole-
sions. We found that only the JNK inhibitor influenced UVB-induced overexpression of cyclin
E1 and p15INK4b proteins mainly at 24 hours after UVB irradiation. Reviewing the literature
[80] and comparing the data to our microarray findings (S1 and S2 Tables) forty-two CPD-
dependent genes could be identified that might be regulated through the activation of JNK.
These findings indicate an important role for JNK kinases in the control of gene expression
modulated by CPD photolesions. These genes are involved in cell adhesion, apoptosis, regula-
tion of the cell cycle and transcriptional machineries, cytoskeletal remodelling, cellular devel-
opment, growth and proliferation. Activation of NF-κB and AP-1 transcription factors (the
major downstream targets of the JNK cascade to regulate the expression of several genes
involved in proliferation and survival pathways or inflammation) are candidates to mediate the
effect of JNK upon UVB irradiation [46]. Increased levels of the activated form of JNK have
been shown in UV exposed keratinocytes [81,82]. It has been reported that active JNK is
mainly associated with keratinocyte proliferation and differentiation [80,83]. Some studies
demonstrated enhanced JNK activity in psoriatic and wound-healing epidermal cells [84,85],
as well as in cylindromas and other hair follicle derived tumors [86]. Moreover, experiments
using animal or human tissue samples suggested that the JNK-Ap1 signalling pathway has an
important role in development of squamous cell carcinoma and melanoma [86]. It is also possi-
ble that CPDs (or other UV-induced DNA-lesions) formed in the promoter or enhancer region
of genes alter binding potentials of transcription factor leading to change in gene expression
[87,88]. These published data raise the question whether expression of certain genes can be
changed directly by UV-induced CPDs formed in their promoter region rather than through a
damage-response signalling pathway. The answer to this question should come from studies
with systematic investigation using specific inhibitors of signalling pathways to prove that
indeed the observed transcriptional changes is mediated through a CPD-dependent signalling
event or caused by a change in the promoter. Studies are ongoing to discern the mechanisms of
CPD photolesion-mediated activation of JNK and its downstream effectors.
Conclusion
We demonstrated that in vitro-transcribed mRNA encoding non-human CPD-photolyase can
efficiently be translated into a functional protein in cultured human keratinocytes. Using pseu-
douridine-modified mRNA encoding CPD-specific photolyase, which can specifically remove
UVB-induced CPD lesions after exposure to photoreactivating light, we found that the CPD
lesions represents the major contributors to the transcriptional response to UVB irradiation.
Network analysis of CPD-regulated genes revealed that CPDs are principal mediators of bio-
logical processes related to cell cycle signalling and transcriptional control. Consequently, the
presence of CPDs modulated the transcription profile of many genes that are involved in the
regulation of cell cycle (e.g. CCNE1, CDKN2B) or function as transcription factors (e.g. ATF3,
ID2, RUNX1). Taken together, the results presented here demonstrates that an approach based
on transfection of in vitro-transcribed mRNA is suitable for distinguishing UVB-induced
CPD-dependent and-independent cellular mechanisms, and explore the molecular details of
the involved signalling pathways.
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In vitro-transcribed mRNA can be easily generated and it is a new platform for the delivery
of therapeutic proteins opening wide perspectives for dermatological or other medical utiliza-
tions. This novel mRNA-based model provides an opportunity to identify additional UV-spe-
cific molecular targets and achieve a better understanding of UVB-mediated skin diseases.
Supporting Information
S1 Fig. Divergence of UVB-mediated gene expression changes using CPD-specific
photolyase encoded by in vitro-transcribed mRNA. To characterize the expression profile of
CPD-related genes, oligonucleotide microarray was carried out as described in Materials and
Methods. Bar graph represents the total number of UVB-responsive genes determined 6 and
24 h after the exposure. Bioset was divided into CPD-independent (the presence of active
photolyase had no effect on the expression level of genes modified by UVB irradiation) and
CPD-dependent (the presence of active photolyase has restored the expression level of genes
modified by UVB irradiation) genes. Cut-off values for changes in gene expression were set
at ± 2-fold.
(PDF)
S2 Fig. Top network interactions among CPD-dependent genes determined at 6 and 24 h
after UVB irradiation in CPD-PLC-mRNA transfected keratinocytes. To analyze network
interactions of CPD-dependent genes, datasets representing differentially regulated genes
derived from microarray were imported into the Ingenuity Pathway Analysis (IPA) applica-
tion. The list of the top three networks and associated cellular functions of all CPD-related
gene datasets are shown with their respective scores and p-values (p< 0.05) obtained from
IPA (panel A). The score is derived from a p-value and indicates the likelihood of the focus
genes in a network being found together due to random chance (defined as:—log10 (p-value)).
The most highly rated networks of genes, determined 6 (panel B) and 24 h (panel C) after UVB
irradiation, are illustrated with the significantly up- (red shaded) and downregulated (green
shaded) genes modulated in a CPD-dependent manner. Genes in empty nodes were not identi-
fied as differentially expressed in our experiment and were generated automatically by IPA
Knowledge Base indicating a relevance to this network. The genes marked with blue circle have
been validated by RT-qPCR.
(PDF)
S3 Fig. Functional classification of CPD-related genes belonging to top rated networks
determined by IPA. To analyze functional classification of CPD-responsive genes belonging
to top networks, datasets derived from the results of network analysis were imported into the
Database for Annotation, Visualization and Integrated Discovery (DAVID) tool. The list of
these CPD-dependent genes, determined at 6 and 24 h after UVB irradiation is shown accord-
ing to their cellular functions (panel A-G). Gene expression values measured in photolyase
mRNA transfected and UVB irradiated cells (PL+UVB) were compared to those measured in
non-UVB irradiated control cells, while photolyase mRNA transfected, UVB-irradiated and
photoreactivated samples (active CPD-photolyase) were compared to those that were photo-
lyase mRNA transfected and UVB irradiated, but left without photoreactivation (inactive
CPD-photolyase). Cut-off values for changes in gene expression were set at ± 2-fold. To evalu-
ate statistical analysis unpaired, Student’s t-test followed by Benjamini-Hochberg corrections
were used. The genes marked with red boxes were selected for further investigation. The blue
box in (F) represents a gene (IL6) that was confirmed in previous work [19] to have CPD-
dependent changes in expression.
(PDF)
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S1 Table. List of all up and downregulated genes related to CPD lesions determined in
CPD-PLC-mRNA transfected human keratinocytes at 6 h after UVB exposure by microar-
ray analyses.
(DOCX)
S2 Table. List of all up and downregulated genes related to CPD lesions determined in
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